
TY  - JOUR
TI  - Surgical research society abstracts
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 77
IS  - 6
SN  - 0007-1323
UR  - https://doi.org/10.1002/bjs.1800770635
DO  - doi:10.1002/bjs.1800770635
SP  - A691
EP  - A713
PY  - 1990
ER  - 

TY  - JOUR
TI  - American Society for Laser Medicine and Surgery Abstracts
JO  - Lasers in Surgery and Medicine
JA  - Lasers Surg. Med.
VL  - 43
IS  - S23
SN  - 0196-8092
UR  - https://doi.org/10.1002/lsm.21034
DO  - doi:10.1002/lsm.21034
SP  - 907
EP  - 1018
PY  - 2011
ER  - 

TY  - JOUR
TI  - Poster Session 1
JO  - European Journal of Heart Failure
JA  - Eur J Heart Fail
VL  - 16
IS  - s2
SN  - 1388-9842
UR  - https://doi.org/10.1002/ejhf.93_4
DO  - doi:10.1002/ejhf.93_4
SP  - 19
EP  - 98
PY  - 2014
ER  - 

TY  - JOUR
TI  - Oral Presentations
JO  - Journal of Inherited Metabolic Disease
JA  - J Inherit Metab Dis
VL  - 41
IS  - S1
SN  - 0141-8955
UR  - https://doi.org/10.1007/s10545-018-0233-9
DO  - doi:10.1007/s10545-018-0233-9
SP  - 37
EP  - 219
PY  - 2018
ER  - 

TY  - JOUR
TI  - Scientific Abstracts and Sessions
JO  - Medical Physics
JA  - Med. Phys.
VL  - 44
IS  - 6
SN  - 0094-2405
UR  - https://doi.org/10.1002/mp.12304
DO  - doi:10.1002/mp.12304
SP  - 2721
EP  - 3318
PY  - 2017
ER  - 

TY  - JOUR
TI  - Proceedings of the 107th Meeting of the British Neuropathological Society held at the Institute of Child Health, London
JO  - Neuropathology and Applied Neurobiology
VL  - 32
IS  - 2
SN  - 0305-1846
UR  - https://doi.org/10.1111/j.1365-2990.2006.00749.x
DO  - doi:10.1111/j.1365-2990.2006.00749.x
SP  - 221
EP  - 249
PY  - 2006
ER  - 

TY  - JOUR
TI  - Published Only
JO  - Journal of Digestive Diseases
JA  - Journal of Digestive Diseases
VL  - 16
IS  - S1
SN  - 1751-2972
UR  - https://doi.org/10.1111/1751-2980.12277
DO  - doi:10.1111/1751-2980.12277
SP  - 29
EP  - 146
PY  - 2015
ER  - 

TY  - JOUR
TI  - Abstracts from the Fourth Chinese Congress on Gerontology and Health Industry
JO  - Journal of the American Geriatrics Society
JA  - J Am Geriatr Soc
VL  - 63
IS  - S2
SN  - 0002-8614
UR  - https://doi.org/10.1111/jgs.13704
DO  - doi:10.1111/jgs.13704
SP  - S323
EP  - S410
PY  - 2015
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Fundamental & Clinical Pharmacology
VL  - 23
IS  - s1
SN  - 0767-3981
UR  - https://doi.org/10.1111/j.1472-8206.2009.00689.x
DO  - doi:10.1111/j.1472-8206.2009.00689.x
SP  - 1
EP  - 112
PY  - 2009
ER  - 

TY  - JOUR
TI  - Basic and clinical science posters
JO  - Diabetic Medicine
JA  - Diabet. Med.
VL  - 31
IS  - s1
SN  - 0742-3071
UR  - https://doi.org/10.1111/dme.12378_1
DO  - doi:10.1111/dme.12378_1
SP  - 28
EP  - 73
PY  - 2014
ER  - 

TY  - JOUR
TI  - POSTER SESSIONS
JO  - Allergy
VL  - 63
IS  - s88
SN  - 0105-4538
UR  - https://doi.org/10.1111/j.1398-9995.2008.01760.x
DO  - doi:10.1111/j.1398-9995.2008.01760.x
SP  - 158
EP  - 611
PY  - 2008
ER  - 

TY  - JOUR
TI  - TSANZ Poster Presentations
JO  - Respirology
JA  - Respirology
VL  - 22
IS  - S2
SN  - 1323-7799
UR  - https://doi.org/10.1111/resp.13010
DO  - doi:10.1111/resp.13010
SP  - 101
EP  - 193
PY  - 2017
ER  - 

TY  - JOUR
AU  - Hausott, Barbara
AU  - Kurnaz, Isil
AU  - Gajovic, Srecko
AU  - Klimaschewski, Lars
TI  - Signaling by Neuronal Tyrosine Kinase Receptors: Relevance for Development and Regeneration
JO  - The Anatomical Record
JA  - Anat Rec
VL  - 292
IS  - 12
SN  - 1932-8486
UR  - https://doi.org/10.1002/ar.20964
DO  - doi:10.1002/ar.20964
SP  - 1976
EP  - 1985
KW  - signaling
KW  - receptor
KW  - neurotrophic
PY  - 2009
AB  - Abstract Receptor tyrosine kinase activation by binding of neurotrophic factors determines neuronal morphology and identity, migration of neurons to appropriate destinations, and integration into functional neural circuits as well as synapse formation with appropriate targets at the right time and at the right place. This review summarizes the most important aspects of intraneuronal signaling mechanisms and induced gene expression changes that underlie morphological and neurochemical consequences of receptor tyrosine kinase activation in central and peripheral neurons. Anat Rec, 292:1976?1985, 2009. ? 2009 Wiley-Liss, Inc.
ER  - 

TY  - JOUR
AU  - van Weerd, Jasper
AU  - Karperien, Marcel
AU  - Jonkheijm, Pascal
TI  - Supported Lipid Bilayers for the Generation of Dynamic Cell–Material Interfaces
JO  - Advanced Healthcare Materials
JA  - Adv. Healthcare Mater.
VL  - 4
IS  - 18
SN  - 2192-2640
UR  - https://doi.org/10.1002/adhm.201500398
DO  - doi:10.1002/adhm.201500398
SP  - 2743
EP  - 2779
KW  - supported lipid bilayers
KW  - cell interfaces
KW  - cell–cell contacts
KW  - cell–extracellular matrix contacts
KW  - biomimicry
PY  - 2015
AB  - Supported lipid bilayers (SLB) offer unique possibilities for studying cellular membranes and have been used as a synthetic architecture to interact with cells. Here, the state-of-the-art in SLB-based technology is presented. The fabrication, analysis, characteristics and modification of SLBs are described in great detail. Numerous strategies to form SLBs on different substrates, and the means to patteren them, are described. The use of SLBs as model membranes for the study of membrane organization and membrane processes in vitro is highlighted. In addition, the use of SLBs as a substratum for cell analysis is presented, with discrimination between cell?cell and cell?extracellular matrix (ECM) mimicry. The study is concluded with a discussion of the potential for in vivo applications of SLBs.
ER  - 

TY  - JOUR
TI  - XLIV ESAO and VII IFAO Congress, 6-9 September 2017, Vienna, Austria
JO  - Artificial Organs
JA  - Artificial Organs
VL  - 41
IS  - 9
SN  - 0160-564X
UR  - https://doi.org/10.1111/aor.13019
DO  - doi:10.1111/aor.13019
SP  - A1
EP  - A81
PY  - 2017
ER  - 

TY  - JOUR
AU  - Baumhoer, Daniel
AU  - Amary, Fernanda
AU  - Flanagan, Adrienne M.
TI  - An update of molecular pathology of bone tumors. Lessons learned from investigating samples by next generation sequencing
JO  - Genes, Chromosomes and Cancer
JA  - Genes Chromosomes Cancer
VL  - 58
IS  - 2
SN  - 1045-2257
UR  - https://doi.org/10.1002/gcc.22699
DO  - doi:10.1002/gcc.22699
SP  - 88
EP  - 99
KW  - bone tumor
KW  - FISH
KW  - genomics
KW  - mutations
KW  - next generation sequencing
KW  - sarcoma
PY  - 2019
AB  - Abstract The last decade has seen the majority of primary bone tumor subtypes become defined by molecular genetic alteration. Examples include giant cell tumour of bone (H3F3A p.G34W), chondroblastoma (H3F3B p.K36M), mesenchymal chondrosarcoma (HEY1-NCOA2), chondromyxoid fibroma (GRM1 rearrangements), aneurysmal bone cyst (USP6 rearrangements), osteoblastoma/osteoid osteoma (FOS/FOSB rearrangements), and synovial chondromatosis (FN1-ACVR2A and ACVR2A-FN1). All such alterations are mutually exclusive. Many of these have been translated into clinical service using immunohistochemistry or FISH. 60% of central chondrosarcoma is characterised by either isocitrate dehydrogenase (IDH) 1 or IDH2 mutations distinguishing them from other cartilaginous tumours. In contrast, recurrent alterations which are clinically helpful have not been found in high grade osteosarcoma. High throughput next generation sequencing has also proved valuable in identifying germ line alterations in a significant proportion of young patients with primary malignant bone tumors. These findings will play an increasing role in reaching a diagnosis and in patient management.
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Clinical & Experimental Ophthalmology
VL  - 37
IS  - s1
SN  - 1442-6404
UR  - https://doi.org/10.1111/j.1442-9071.2009.02174.x
DO  - doi:10.1111/j.1442-9071.2009.02174.x
SP  - A62
EP  - A99
PY  - 2009
ER  - 

TY  - JOUR
TI  - Poster Presentations
JO  - The FEBS Journal
VL  - 276
IS  - s1
SN  - 1742-464X
UR  - https://doi.org/10.1111/j.1742-4658.2009.07049.x
DO  - doi:10.1111/j.1742-4658.2009.07049.x
SP  - 95
EP  - 356
PY  - 2009
ER  - 

C7  - pp. 355-381
TI  - Sarcomatoid Carcinoma (Carcinosarcoma)
SN  - 9780470571088
UR  - https://doi.org/10.1002/9781118275436.ch16
DO  - doi:10.1002/9781118275436.ch16
SP  - 355-381
KW  - sarcomatoid carcinoma (carcinosarcoma)
KW  - tumors, identifiable malignant epithelial cells and sarcoma types
KW  - sarcomatoid carcinoma, at sites of urothelial epithelium
KW  - molecular pathology of sarcomatoid carcinoma
KW  - sarcomatoid carcinoma, uncommon tumors, therapeutic/prognostic implications
PY  - 2009
AB  - Summary This chapter contains sections titled: Overview Definition and Terminology Clinical Presentation Pathology Ultrastructural Features Immunohistochemistry and Differential Diagnosis Upper Urinary Tract Sarcomatoid Carcinoma Prognosis and Treatment Molecular Pathology of Sarcomatoid Carcinoma Summary and Future Perspectives References
ER  - 

TY  - JOUR
TI  - The 54th Annual Congress
JO  - Journal of Obstetrics and Gynaecology Research
VL  - 28
IS  - 1
SN  - 9780470571088
UR  - https://doi.org/10.1046/j.1341-8076.2002.00281.x
DO  - doi:10.1046/j.1341-8076.2002.00281.x
SP  - 38
EP  - 65
PY  - 2002
ER  - 
